Kras mutation correlating with circulating regulatory T cells predicts the prognosis of advanced pancreatic cancer patients

PURPOSE: Kras mutation and abnormal immune status are associated with pancreatic cancer development and progression. In this study, we evaluated the Kras mutation status in circulating tumor DNA and circulating T cell subsets in a cohort of advanced pancreatic cancer patients. METHODS: Samples were...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, He, Luo, Guopei, Jin, Kaizhou, Fan, Zhiyao, Huang, Qiuyi, Gong, Yitao, Xu, Jin, Yu, Xianjun, Liu, Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064028/
https://www.ncbi.nlm.nih.gov/pubmed/32017404
http://dx.doi.org/10.1002/cam4.2895

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064028/
https://www.ncbi.nlm.nih.gov/pubmed/32017404
http://dx.doi.org/10.1002/cam4.2895

Ejemplares similares